SSYS Stratasys Ltd.
Stratasys Ltd. provides connected polymer-based 3D printing solutions. It offers range of 3D printing systems, including polyjet printers, fused deposition modeling (FDM) printers designed for prototyping, manufacturing tools, and production parts; PolyJet printers to print multiple materials including color printing in a single part build; pantone having validated colors, and multiple material properties; TechStyleTM, which allows 3D printing directly on different kinds of fabrics, enabling series productions in the fashion industry; Anatomy, which helps medical device companies optimize design throughout the product lifecycle; GelMatrix resin; TissueMatrix resin; BoneMatrix resin; and Digital Anatomy Creator to create different anatomical structures by customizing specific bio-mechanical properties and color. It also offers GrabCAD software for medical users; J35 Pro 3D an all-in-one, multi material desktop 3D printer; 5 DentaJet and J3 DentaJet for the dental and medical; stereolithography printers; Neo range of industrial stereolithography (SLA) 3D printers; Somos resin; Titanium control software; and Origin P3 printer; Origin 3D printers; SAF printers. In addition, it provides consumables, software, paid parts, and professional services; and prototyping, design, and manufacturing aids and production solutions. Stratasys Ltd. is headquartered in Minnetonka, Minnesota.…
Industry Peers
Computer HardwareKey Statistics
About Stratasys (NASDAQ: SSYS)
›
Stratasys (NASDAQ: SSYS) is listed on Nasdaq, where its shares trade in USD. It belongs to the Computer Hardware industry, part of the Technology sector, and reports about 1,757 employees.
The shares were at 5.490 USD on 19 November 2026, down 42.0% over 52 weeks. Its 52-week range is 5.440 USD to 12.24 USD, and it trades at the bottom of that range.
Its market capitalisation is 483.62M USD.
Stratasys reports return on equity of -12.4%, an operating margin of -10.9% and revenue up 4.1% year over year.
It holds more cash than debt, a net cash position of 184.40M USD. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 3 analysts cover the stock, with an average rating of Buy; their mean price target of 9.667 USD is 76.1% above the current price. The next earnings report is expected on 4 March 2027.